1. Volume 63, Issue 1, Pages 158-165 (January 2013)
Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled Trial 
Steven A. Kaplan, Weizhong He, William D. Koltun, Jana Cummings, Tim Schneider, Allam Fakhoury 
European Urology 
Volume 63, Issue 1, Pages (January 2013)
DOI: /j.eururo
Copyright © 2012 European Association of Urology Terms and Conditions

2. Fig. 1
Study flow diagram. BOOI=bladder outlet obstruction index; IPSS=International Prostate Symptom Score; TOCAS=tamsulosin oral controlled absorption system; SOLI=solifenacin; AE=adverse events.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

3. Fig. 2
Detrusor pressure at maximum flow rate (PdetQmax): within–treatment-group mean change from baseline to week 12 and end of treatment (EOT) in the full analysis set. *p<0.005 (based on t test for change from baseline within treatment). SOLI=solifenacin; TOCAS=tamsulosin oral controlled absorption system.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

4. Fig. 3
Maximum flow rate (Qmax): within–treatment-group mean change from baseline to week 12 and end of treatment (EOT) in the full analysis set. **p< (based on t test for change from baseline within treatment). SOLI=solifenacin; TOCAS=tamsulosin oral controlled absorption system.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

5. Fig. 4
Postvoid residual volume (PVR): within–treatment-group mean change from baseline in the safety analysis set. *p<0.05, **p<0.005, ***p< (based on t test for change from baseline within treatment). EOT=end of treatment; SOLI=solifenacin; TOCAS=tamsulosin oral controlled absorption system.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions

6. Fig. 5
Average voided volume per micturition: change from baseline. *p<0.05, **p<0.005, ***p< EOT=end of treatment; SOLI=solifenacin; TOCAS=tamsulosin oral controlled absorption system.
European Urology  , DOI: ( /j.eururo )
Copyright © 2012 European Association of Urology Terms and Conditions